Hexagon Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25
| Closed | -$851 | – | 433 |
|
|
2025
Q1 | $851 | Buy |
25
+9
| +56% | +$306 | ﹤0.01% | 1578 |
|
|
2024
Q4 | $630 | Buy |
16
+14
| +700% | +$551 | ﹤0.01% | 1661 |
|
|
2024
Q3 | $94 | Buy |
+2
| New | +$94 | ﹤0.01% | 1541 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$41 | – | 1461 |
|
|
2022
Q4 | $41 | Sell |
1
-12
| -92% | -$492 | ﹤0.01% | 1437 |
|
|
2022
Q3 | $1K | Buy |
13
+12
| +1,200% | +$923 | ﹤0.01% | 1187 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1184 |
|